I-PREX

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameI-PREX
Drug Alias NamerBPI anti-bacterial (Allergan)rBPI anti-bacterial (XOMA)rBPI-21 formulations (XOMA)I-PREX
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXoma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXoma CorpAllergan Inc
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A